University Hospital and New Jersey Medical School (NJMS) are, through their joint FDA-approved convalescent plasma program, collecting plasma donations from patients who have recovered from COVID-19 and infusing it into patients still struggling to fight off the virus. Marc Klapholz, chair of NJMS” Department of Medicine and the hospital’s chief of medical service, explains that the presumed antibodies in the plasma may improve seriously ill patients’ chances for survival. To read the full article.
Recent Posts
- Two-Thirds of U.S. Adolescent Minors Are Impacted by State Abortion Restrictions.
- Virtual Trial Shows Combo Rescue Inhaler Nearly Halves Severe Asthma Attacks.
- Scientists Develop Process Using Molecules in the Cell to Identify Environmental Signals.
- Learning Health System Scholars Training Program – 2025 RFA Open Now!
- Tracking Tiny Facial Movements Can Reveal Subtle Emotions in Autistic Individuals.
Categories
- Community (2,254)
- Covid (986)
- CTO Events (6)
- News (2,871)
- Pilots (21)